Click here to subscribe to Biomedical Materials and immediately access all its archives
Click here to review the contents of the October 2008 issue of Biomedical Materials and download it online
Issue: October 2008, page: 1
Nanotherapeutics seeks approval for hydrogel wound treatment
Biopharmaceutical company Nanotherapeutics has applied to the US Food and Drug Administration (FDA) for its first Investigational New Drug (IND) approval. The company wants to carry out a Phase IIa clinical study for a topical doxycycline hydrogel for chronic wounds.
